SM
Shiv Mohan Awasthi
About Shiv Mohan Awasthi
Data last updated:
Shiv Mohan Awasthi is a Director at Medleon Pharmaceutical Private Limited (since 2022), Director at Genesis Medipharma Private Limited (since 2006) and Designated Partner at Medleon Healthcare Llp (since 2022), and holds 1 more current directorship. The companies operate in Pharma, Chemicals and Business Services. The 2 current companies with reported revenue have a combined latest revenue of ₹16.9 Lakh; the largest is Medleon Pharmaceutical Private Limited at ₹16.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 13 Sep 2022 | 2022 | ₹16.8 Lakh (FY 2025) | Active | |
| Director | 29 Mar 2006 | 2006 | ₹10,870 (FY 2025) | Active | |
| Designated Partner | 04 May 2022 | 2022 | Active | ||
| Designated Partner | 15 Feb 2022 | 2022 | Active |
Board colleagues of Shiv Mohan Awasthi
| Name | DIN | Company | Designation |
|---|---|---|---|
| Suman Misra | 10363334 | Medleon Pharmaceutical Private Limited | Director |
| Neetu Singh | 07730635 | Genesis Medipharma Private Limited | Director |
| Ritu Kumari | 09506797 | Medleon Healthcare Llp , Marwin Healthcare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shiv Mohan Awasthi
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shiv Mohan Awasthi
Shiv Mohan Awasthi currently holds 4 directorships: Medleon Pharmaceutical Private Limited (Director, since 13 Sep 2022, revenue ₹16.8 Lakh (FY 2025)); Genesis Medipharma Private Limited (Director, since 29 Mar 2006, revenue ₹10,870 (FY 2025)); Medleon Healthcare Llp (Designated Partner, since 04 May 2022); Marwin Healthcare Llp (Designated Partner, since 15 Feb 2022).
Shiv Mohan Awasthi was first appointed on 29 Mar 2006 as Director at Genesis Medipharma Private Limited. The most recent appointment on record is 13 Sep 2022 at Medleon Pharmaceutical Private Limited.
The 2 current companies of Shiv Mohan Awasthi that report revenue have a combined latest revenue of ₹16.9 Lakh: Medleon Pharmaceutical Private Limited ₹16.8 Lakh (FY 2025); Genesis Medipharma Private Limited ₹10,870 (FY 2025).
The current boards of Shiv Mohan Awasthi's companies include Suman Misra (Medleon Pharmaceutical Private Limited), Neetu Singh (Genesis Medipharma Private Limited), Ritu Kumari (Medleon Healthcare Llp).